Peter Peizhi LUO,Fangyong DU,Zhongzong PAN,Guizhong LIU
申请号：
US16265946
公开号：
US20190241662A1
申请日:
2019.02.01
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Provided herein are cross-reactive antibodies (or antigen binding fragments thereof) that bind to human CTLA4, activatable antibodies that bind to human CTLA4, nucleic acid molecules encoding the same, pharmaceutical compositions thereof, and methods of their therapeutic use (e.g., for treatment of cancer).
